Herschorn, S., Nazir, J., Ramos, B., & Hakimi, Z. (2017). Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada. Can Urol Assoc J.
シカゴスタイル引用形Herschorn, Sender, Jameel Nazir, Barbara Ramos, , Zalmai Hakimi. "Cost-effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada." Can Urol Assoc J 2017.
MLA引用形式Herschorn, Sender, Jameel Nazir, Barbara Ramos, , Zalmai Hakimi. "Cost-effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada." Can Urol Assoc J 2017.
警告: この引用は必ずしも正確ではありません.